Cabaletta Bio (CABA) is scheduled to report Q1 earnings on May 14, 2026. Analysts estimate EPS of $-0.40 and quarterly revenue of N/A.
In the most recent quarter (Q4), Cabaletta Bio reported EPS of $-0.40, beating estimates of $-0.46 by 0.13%. Revenue came in at $0.00, missing the estimate of $833.33K by 1.00%.
Cabaletta Bio has beaten EPS estimates in 2 consecutive quarters.
Over the last 4 quarters, Cabaletta Bio has averaged an EPS surprise of 0.10% and a revenue surprise of 1.00%.
Analyze the earnings history of Cabaletta Bio using advanced sorting and filters.
The chart below shows Cabaletta Bio's reported EPS compared to analyst estimates over recent quarters.
The chart below shows Cabaletta Bio's reported revenue compared to analyst estimates over recent quarters.
Cabaletta Bio (CABA) is scheduled to report earnings on May 14, 2026. The last reported earnings were for reported on March 23, 2026 for Q4.
The Actual EPS was $-0.40, which beat the estimate of $-0.46.
The Actual Revenue was $0.00, which missed the estimate of $833.33K.
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q4 | 2026-03-23 | $-0.40 | $-0.46 | 13.0 % |
| Q3 | 2025-11-10 | $-0.44 | $-0.47 | 6.38 % |
| Q2 | 2025-08-07 | $-0.73 | $-0.65 | -12.3 % |
| Q1 | 2025-05-15 | $-0.71 | $-0.66 | -7.58 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q4 | 2026-03-23 | $0 | $833.33K | -100.0 % |
| Q3 | 2025-11-10 | $0 | $833.33K | -100.0 % |
| Q2 | 2025-08-07 | $0 | $4.17M | -100.0 % |